<SEC-DOCUMENT>0001683168-24-005910.txt : 20250227
<SEC-HEADER>0001683168-24-005910.hdr.sgml : 20250227
<ACCEPTANCE-DATETIME>20240819165705
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001683168-24-005910
CONFORMED SUBMISSION TYPE:	DRSLTR
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240819

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CLOUDASTRUCTURE, INC.
		CENTRAL INDEX KEY:			0001709628
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				870690564
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DRSLTR

	BUSINESS ADDRESS:	
		STREET 1:		228 HAMILTON AVENUE
		STREET 2:		3RD FLOOR
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94301
		BUSINESS PHONE:		650-644-4160

	MAIL ADDRESS:	
		STREET 1:		228 HAMILTON AVENUE
		STREET 2:		3RD FLOOR
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94301

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Connexed Technologies Inc.
		DATE OF NAME CHANGE:	20170619
</SEC-HEADER>
<DOCUMENT>
<TYPE>DRSLTR
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 90px; width: 225px">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0 0pt 4in">August 19, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Confidential Submission Via EDGAR</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Draft Registration Statement<BR>
U.S. Securities and Exchange Commission<BR>
Division of Corporation Finance<BR>
100 F. Street, N.E.<BR>
Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 13%; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 10pt">RE:</FONT></TD>
    <TD STYLE="width: 87%">
    <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cloudastructure, Inc.</P>
    <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Draft Registration Statement on Form S-1</P>
    <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Submitted July 9,
2024</P>
    <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">CIK No. 0001709628</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">On behalf of Cloudastructure, Inc., a Delaware corporation
(the &ldquo;Company&rdquo;), we are submitting this letter in response to a letter, dated August 5, 2024, from the staff (the &ldquo;Staff&rdquo;)
of the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) with respect to the Company&rsquo;s Draft Registration Statement
on Form S-1, confidentially submitted to the Commission on July 8, 2024 (the &ldquo;Draft Registration Statement&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">Concurrently with the submission of this letter,
the Company is confidentially submitting, through the Commission&rsquo;s Electronic Data Gathering, Analysis and Retrieval (&ldquo;EDGAR&rdquo;)
system, an amendment to the Draft Registration Statement (the &ldquo;Amendment&rdquo;) in response to the Staff&rsquo;s comments and to
reflect certain other changes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">The numbered paragraphs below correspond to the numbered
comments in the Staff&rsquo;s letter and the Staff&rsquo;s comments are presented in bold italics. All references to page numbers and
captions (other than those in the Staff&rsquo;s comments and unless otherwise stated) correspond to the page numbers and captions in the
Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Draft Registration Statement on Form S-1 submitted July 9, 2024</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Prospectus Summary, page 2</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>1.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>Please provide the basis for your claim that in 2023 your Remote Guarding services &ldquo;deterred
over 97% of all threatening incidences&rdquo; for your customers.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and has revised the disclosure on pages 3, 22, 31 and 33 of the Amendment to provide additional detail regarding the basis for its 97%
deterrence rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Risk Factors, page 6</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>2.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>To the extent material, please revise your risk factor disclosure to address: risk that the opening
trading price may not be related to historical sales prices; uncertainty associated with the fact that few companies have undertaken direct
listings to date; and any impact of the company&rsquo;s brand and consumer recognition on the demand for shares.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and has added additional risk factor disclosure on pages 14 and 17 of the Amendment, addressing the risk that the opening trading price
may not be related to historical sales prices; uncertainty associated with the fact that few companies have undertaken direct listings
to date; and the impact of awareness of the Company&rsquo;s brand and investor recognition of the Company on the demand for shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>3.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>Please provide risk factor disclosure addressing the material factors that raise substantial doubt
about your ability to continue as a going concern.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and has added additional risk factor disclosure on page 12 of the Amendment, addressing the material factors that raise substantial doubt
about the Company&rsquo;s ability to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>4.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>We note your disclosure on page 43 that, in 2023, three customers accounted for 40% of your revenue
and that, in 2022, three customers accounted for 46% of your revenue. Please provide risk factor disclosure regarding risks stemming from
your customer concentration.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and has added additional risk factor disclosure on page 13 of the Amendment regarding risks stemming from our customer concentration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>5.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>We note your disclosure elsewhere regarding your obligations to indemnify. Please clarify whether
you have agreed to indemnify certain the Registered Stockholders for certain claims arising in connection with sales under this prospectus.
If so, discuss the impact, if any, of large indemnity payments on the company.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and has added additional risk factor disclosure beginning on page 17 of the Amendment, clarifying that the Company has not agreed to indemnify
the Registered Stockholders for claims arising in connection with sales under the prospectus that forms a part of the registration statement,
and addressing the impact of large indemnity claims by directors and officers on the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Results of Operations, page 26</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>6.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>We note you describe multiple factors that impacted your results of operations; however, you do
not appear to quantify the impact of or explain the drivers behind each factor. For example:</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD><FONT STYLE="font-size: 10pt"><B><I>You indicate that cloud video surveillance revenue, remote guarding revenue, and hardware revenue
increased by 66%, 1948% and 4622%, respectively, in the first three months of 2024 compared to the first three months of 2023.</I></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD><FONT STYLE="font-size: 10pt"><B><I>You attribute increased cost of goods sold in the first three months of 2024 to increased sales
costs, such as hosting costs, the costs of equipment sold, installation costs and the costs of your operations department.</I></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD><FONT STYLE="font-size: 10pt"><B><I>You attribute the increase in revenue for fiscal year 2023 to your expanded customer base.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 44.65pt"><B><I>Please revise throughout to quantify each material
factor, including any offsetting factors that contributed to your results of operations including a quantified discussion for each service
or product offering that contributed to such a change. In addition, you should refrain from using qualitative terms such as &ldquo;primarily&rdquo;
in lieu of providing specific quantitative disclosure. Refer to Item 303(b) of Regulation S-K.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 44.65pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 44.6pt">The Company respectfully acknowledges the Staff&rsquo;s
comment and has added additional disclosure throughout the Results of Operations beginning on page 25 of the Amendment to quantify the
impact of, or explain the drivers behind, the material factors that contributed to its results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 44.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Liquidity and Capital Resources, page 29</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>7.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>You indicate that your anticipated operating requirements for the next twelve months, assuming
the maintenance of your current operations, exceed your available capital resources. Please expand your disclosure to include your estimated
material cash requirements over the next twelve months and describe the level of operations that you will be able to perform with your
existing capital resources and liquidity.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and has added additional disclosure beginning on page 28 of the Amendment to address its material cash requirements over the next twelve
months and measures that the Company may take to conserve liquidity and capital resources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>8.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>Please revise to include a discussion of your cash flows from operating, investing and financing
activities.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and has added additional disclosure beginning on page 27 of the Amendment to address cash flows from operating and financing activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Our Key Customers, page 42</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>9.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>Please clarify the term &ldquo;sales&rdquo; as used in relation to your discussion of key customers
in the first paragraph on page 44.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and has revised the disclosure on page 44 of the Amendment to replace the term &ldquo;sales&rdquo; with the more accurate term &ldquo;revenues.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>10.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>We note your disclosure that you have strategically partnered with &ldquo;some of the largest
property management groups in the industry.&rdquo; Please discuss your strategic partnerships with each of these brands and the amount
of revenue you generate from these customers, if material. Please avoid highlighting customers based on the customers&rsquo; size or name
recognition rather than their contribution to your business.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and has revised the disclosure on page 40 of the Amendment regarding its relationships with its key customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Business</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Regulatory Environment, page 44</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>11.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>Please expand your disclosure regarding the laws and regulations central to your business to which
you are subject. In addition, you disclose on page 38 that your customers are &ldquo;responsible for their own compliance with applicable
laws and regulations&rdquo; with regard to the use of your Facial Recognition technology. Please describe whether you are subject to liability
or laws with respect to your customers&rsquo; use of your technology. Provide related risk factor disclosure, if material.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and has revised the disclosure on page 37 to discuss the laws and regulations central to the Company&rsquo;s business and the relationship
between the Company&rsquo;s and its customers&rsquo; compliance roles. The Company has also added additional risk factor disclosure on
page 6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Principal and Registered Stockholders, page 60</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>12.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>Please identify the natural person or persons who have voting and/or investment control of the
shares held by Upward Labs AC/SB LLC and disclose whether you have any material relationships with this shareholder. Further, revise the
chart to indicate which columns represent holdings of Class A and Class B shares.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and has revised the chart to identify the natural person who has voting and investment control of the shares held by Upwards Labs AC/SB
LLC. The Company advises the Staff that it does not have any material relationships with this shareholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Description of Capital Stock, page 62</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>13.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>Please revise to provide a more detailed description of the material voting rights of the Class
A common stockholders. For example, disclose under what circumstances Class A common stockholders are entitled to a separate class vote
under Delaware law.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and has revised the disclosure on page 51 of the Amendment to provide a more detailed description of the material voting rights of the
Class A common stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Exclusive Forum, page 64</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>14.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>We note your disclosure that your forum selection provision identifies the federal district courts
of the United States of America as the exclusive forum for claims arising under the Securities Act. Please disclose that there is uncertainty
as to whether a court would enforce such provision and that investors cannot waive compliance with the federal securities laws and the
rules and regulations thereunder. In this regard, we note that Section 22 of the Securities Act creates concurrent jurisdiction for federal
and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.
In addition, please clarify your disclosure regarding claims arising under the Exchange Act to state clearly that the Exchange Act confers
exclusive federal jurisdiction over such claims.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and has revised the disclosure on page 51 of the Amendment to disclose that Section 22 of the Securities Act creates concurrent jurisdiction
for federal and state courts over all suits brought to enforce a duty or liability created by the Securities Act, that there is uncertainty
as to whether a court would enforce the United States of America as the exclusive forum for claims arising under the Securities Act, and
to clarify that the Exchange Act confers exclusive federal jurisdiction over claims arising under the Exchange Act. The Company has also
added additional risk factor disclosure on page 17.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Plan of Distribution, page 73</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>15.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>Please clarify whether the fee paid to the Advisor is entirely contingent on the successful consummation
of the direct listing or whether any portion of the fee is required to be paid regardless of whether the direct listing is completed.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and has revised the disclosure on page 61 of the Amendment to clarify that the Advisor received 700,000 shares of the Company&rsquo;s
Class A common stock in connection with its engagement that the remaining fees will be contingent on the successful consummation of the
direct listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>16.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>Please discuss the Advisor&rsquo;s role in Nasdaq&rsquo;s price validation test, if any, under
the Nasdaq rules.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and has added disclosure on the cover page and pages 14 and 59 of the Amendment to discuss the Advisor&rsquo;s role in Nadaq&rsquo;s price
validation test under the Nasdaq rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>17.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>Please disclose whether you will be involved in Nasdaq&rsquo;s price-setting mechanism or will
coordinate or be in communication with the Advisor including with respect to any decision by the Advisor to delay or proceed with trading.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and has revised the cover page and page 60 of the Amendment to clarify that we will not be involved in Nasdaq&rsquo;s price-setting mechanism
or will coordinate or be in communication with the Advisor including with respect to any decision by the Advisor to delay or proceed with
trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Financial Statements, page F-3</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>18.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>We note your auditor expressed an opinion on your consolidated balance sheet as of December 31,
2023 and 2022, the related consolidated statements of operations and comprehensive loss, stockholder&rsquo;s equity and cash flows for
the years then ended. We also note:</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD><FONT STYLE="font-size: 10pt"><B><I>the financial statements presented on pages F-3 through F-6 are labelled &ldquo;condensed;&rdquo;</I></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD><FONT STYLE="font-size: 10pt"><B><I>the column headings for the annual periods presented in the statement of operations are 2023 and
2024;</I></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD><FONT STYLE="font-size: 10pt"><B><I>the statement of stockholders&rsquo; equity only includes 2023; and</I></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD><FONT STYLE="font-size: 10pt"><B><I>the statement of cash flows is labelled &ldquo;unaudited.&rdquo;</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B><I>Please revise as necessary to ensure your consolidated
financial statements for 2023 and 2022 are completely and accurately presented.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and advises the Staff that it has revised the:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 56.6pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>financial statement headings on pages F-3 though F-6 of the Amendment to remove the &ldquo;condensed&rdquo; label;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 56.6pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>column headings for the annual periods presented in the statement of operations to reflect 2023 and 2022;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 56.6pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>statement of stockholders&rsquo; equity to include 2023 and 2022; and</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 56.6pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>heading in the statement of cash flows to remove the &ldquo;unaudited&rdquo; label.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company further advises the Staff that it has made additional
revisions throughout its financial statements for 2023 and 2022 to ensure that they are completely and accurately presented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>19.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>We note your disclosure that a non-cash loss on impairment was recorded on December 31, 2023 reflecting
goodwill impairment charges totaling $1.67 million. Please present the impairment loss as a separate line item on the income statement
within continuing operations in accordance with ASC 350-20-45-2 and expand your disclosures related to goodwill to comply with the requirements
of ASC 350-20-50.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and advises the Staff that it has presented &ldquo;Goodwill impairment loss&rdquo; as a separate line item in the Statement of Operations
for the year ended December 31, 2023 on page F-3, in accordance with ASC 350-20-45-2, and has expanded its disclosure in Note 2 &ndash;
Summary of Significant Accounting Policies &ndash; <I>Goodwill</I> on page F-7 to comply with the requirements of ASC 350-20-50.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Note 8 - Subsequent Events, page F-13</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>20.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>It appears you recorded the goodwill impairment in 2023 so it is unclear why you are disclosing
it as a subsequent event. Please remove this disclosure or advise us.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and advises the Staff that it has removed the goodwill impairment disclosure from its &ldquo;Subsequent Events&rdquo; footnote on page
F-10 of the Amendment and presented it as a separate line item in its Statement of Operations on page F-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Condensed Consolidated Statement of Cash Flows, page F-17</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>21.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>We note the reported balance of March 31, 2024 Cash at End of Period is not consistent with cash
on the March 31, 2024 balance sheet. Please revise as necessary.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and advises that it has updated its consolidated financial statements to cover the quarterly period ended June 30, 2024, and has ensured
that the Cash at End of Period on its consolidated statement of cash flows is consistent with the cash on hand reflected on its balance
sheet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>General</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B><I>22.</I></B></TD><TD><FONT STYLE="font-size: 10pt"><B><I>Please supplementally provide us with copies of all written communications, as defined in Rule
405 under the Securities Act, that you, or anyone authorized to do so on your behalf, present to potential investors in reliance on Section
5(d) of the Securities Act, whether or not they retain copies of the communications.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Company respectfully acknowledges the Staff&rsquo;s comment
and advises the Staff that neither it nor anyone authorized by the Company has presented any written communications, as defined in Rule
405 under the Securities Act, to potential investors in reliance on Section 5(d) of the Securities Act. To the extent that any such written
communications are presented to potential investors, the Company will supplementally provide copies to the Staff.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center">*&#9;*&#9;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Should you have any questions or comments concerning
this submission or require any additional information, please do not hesitate to contact me at (212) 980-7208.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 5in">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 5in"><B>SAUL EWING LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 5in"><I><U>/s/ Vanessa
Schoenthaler&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></I><U></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 5in">Vanessa Schoenthaler</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">cc:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">James McCormick, Cloudastructure, Inc.<BR>
Greg Smitherman, Cloudastructure, Inc.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !X 2P# 2(  A$! Q$!_\0
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MO-?7FO:WR,Y\]O<(?^%[>#O^@A+_ . [_P"%'_"]O!W_ $$)?_ =_P#"J_\
MPH#PC_S[W?\ X$M1_P * \(_\^]Y_P"!+5XE^(>U+_R8Q_?^18_X7MX._P"@
MA+_X#O\ X4?\+V\'?]!"7_P'?_"J_P#PH#PC_P ^]W_X$M1_PH#PC_S[W?\
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M47XA[4O_ "8/W_D6/^%[>#O^@A+_ . [_P"%'_"]O!W_ $$)?_ =_P#"J_\
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M47XA[4O_ "8/W_D6/^%[>#O^@A+_ . [_P"%'_"]O!W_ $$)?_ =_P#"J_\
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MO3=IEN/_ "$M?F;_ ,$\YE\+?M;:KH]Z?*NI+/4+%5;@F6.56(^N(V/X5YN
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MUV-<\DDVD[HL****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 FT>E&T>E%% "T444
#?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
